{"id":15382,"date":"2023-10-19T14:03:34","date_gmt":"2023-10-19T12:03:34","guid":{"rendered":"https:\/\/francelyme.fr\/site\/?p=15382"},"modified":"2024-02-04T17:23:48","modified_gmt":"2024-02-04T16:23:48","slug":"resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees","status":"publish","type":"post","link":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/","title":{"rendered":"R\u00e9sultats du protocole du Dr Horowitz \u00e0 base de Dapsone \u00e0 haute dose dans le traitement de la maladie de Lyme chronique et des co-infections associ\u00e9es"},"content":{"rendered":"<div class=\"like-button\" style=\"float: right; clear: both; text-align: right; width = 100%;\">\n<!-- Facebook Like Button Vivacity Infotech BEGIN -->\n<div class=\"fb-like\" data-href=\"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/\" data-layout=\"box_count\" data-action=\"like\" data-show-faces=\"false\" data-size=\"large\" data-width=\"450\" data-share=\"1\" ><\/div><\/div>\n<!-- Facebook Like Button Vivacity Infotech END -->\n<div id=\"fb-root\"><\/div>\n\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile is-vertically-aligned-center\" style=\"grid-template-columns:21% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" decoding=\"async\" width=\"360\" height=\"295\" src=\"http:\/\/francelyme.fr\/site\/wp-content\/uploads\/2014\/10\/m_horowitz.jpg\" alt=\"\" class=\"wp-image-3172 size-full\" srcset=\"https:\/\/francelyme.fr\/site\/wp-content\/uploads\/2014\/10\/m_horowitz.jpg 360w, https:\/\/francelyme.fr\/site\/wp-content\/uploads\/2014\/10\/m_horowitz-300x246.jpg 300w\" sizes=\"auto, (max-width: 360px) 100vw, 360px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p class=\"has-medium-font-size\">Dr Horowitz Richard, docteur r\u00e9put\u00e9 aux USA et dans le monde, et auteur de livres sur la maladie de Lyme et les maladies \u00e0 tique, membre de l&rsquo;ILADS<\/p>\n<\/div><\/div>\n\n\n\n<p>Le Dr Horowitz nous avait d\u00e9crit ses travaux lors d\u2019une conf\u00e9rence en mai dernier, il vient avec son \u00e9quipe de publier mi-septembre les r\u00e9sultats de ses protocoles combin\u00e9s \u00e0 base de Dapsone, dans le journal Microorganisms.<\/p>\n\n\n\n<p>En r\u00e9sum\u00e9, les r\u00e9sultats obtenus dans le traitement de patients Lyme chronique <em>(CLD\/PTLDS en anglais, soit Chronic Lyme Disease \/ Post-Treatment Lyme Disease Syndrome)<\/em> sont conformes \u00e0 ce qu\u2019il nous avait pr\u00e9sent\u00e9 au printemps&nbsp;: sur le groupe de 25 patients qu\u2019il a trait\u00e9s avec son protocole, tous sans exception ont vu leurs sympt\u00f4mes r\u00e9gresser, et plus de 40% d\u2019entre eux sont en r\u00e9mission, toujours en cours, ou ont connu des p\u00e9riodes de r\u00e9mission (la plus longue, toujours en cours, est de 22 mois).<\/p>\n\n\n\n<p><strong>Les auteurs concluent en disant qu\u2019il s\u2019agit du premier protocole g\u00e9n\u00e9rique oral efficace \u00e0 court terme pour traiter la forme chronique de Lyme et les co-infections associ\u00e9es, y compris la Bartonellose<\/strong>.<\/p>\n\n\n\n<p>Dans le d\u00e9tail&nbsp;:<\/p>\n\n\n\n<p>Ils constatent que 8 semaines de protocole \u00ab&nbsp;Dapsone double dose combin\u00e9&nbsp;\u00bb (DDDCT) suivies d&rsquo;une impulsion de 4 jours du protocole \u00ab&nbsp;Dapsone haute dose combin\u00e9&nbsp;\u00bb (HDDCT) sont suffisantes pour mettre les patients Lyme chronique en r\u00e9mission \u00e0 long terme s&rsquo;ils ne pr\u00e9sentent pas de preuves de co-infections actives \u00e0 Babesia et Bartonella.<\/p>\n\n\n\n<p>Les patients co-infect\u00e9s par Bartonella pr\u00e9sentent un tableau plus s\u00e9v\u00e8re, avec davantage de sympt\u00f4mes neuropsychiatriques, un d\u00e9ficit immunitaire et une neuropathie p\u00e9riph\u00e9rique et autonome accrue. Le protocole de 8 semaines de DDDCT suivies d&rsquo;une impulsion de 6-7 jours de HDDDCT am\u00e9liorent les sympt\u00f4mes, et conduisent vers la r\u00e9mission compl\u00e8te dans un grand nombre de cas.<\/p>\n\n\n\n<p>Les patients pr\u00e9sentant des signes de Bartonellose chronique ont obtenu des r\u00e9sultats sup\u00e9rieurs en utilisant 8 semaines de DDDCT suivies d&rsquo;une impulsion de 6-7 jours de HDDCT.<\/p>\n\n\n\n<p>Cela confirme les r\u00e9sultats obtenus par les chercheurs de Johns Hopkins qui ont \u00e9tudi\u00e9 les persistances de Bartonella en culture, o\u00f9 6 jours d&rsquo;antibioth\u00e9rapie combin\u00e9e (rifampicine, azithromycine et bleu de m\u00e9thyl\u00e8ne) ont \u00e9t\u00e9 n\u00e9cessaires pour \u00e9liminer compl\u00e8tement les persistances de Bartonella dans les biofilms.<\/p>\n\n\n\n<p>Les auteurs indiquent qu\u2019ils n&rsquo;ont pas obtenu un taux de r\u00e9ussite de 100% en utilisant 6 jours de Plaquenil, une t\u00e9tracycline (doxycycline ou minocycline), de la rifampicine, de l&rsquo;azithromycine, du pyrazinamide et de la dapsone avec une dose plus \u00e9lev\u00e9e de bleu de m\u00e9thyl\u00e8ne ; cependant, ils ont obtenu des taux de r\u00e9ponse sup\u00e9rieurs dans l&rsquo;am\u00e9lioration g\u00e9n\u00e9rale des sympt\u00f4mes (100%) par rapport aux protocoles ant\u00e9rieurs \u00e0 base de dapsone.<\/p>\n\n\n\n<p>Les protocoles ant\u00e9rieurs comprenaient 8 semaines de DDDCT avec des traitements plus courts de dapsone \u00e0 forte dose (4 jours maximum) et des doses plus faibles de bleu de m\u00e9thyl\u00e8ne. L&rsquo;augmentation de la dose de bleu de m\u00e9thyl\u00e8ne ainsi que l&rsquo;allongement de la dur\u00e9e de la dapsone \u00e0 forte dose (200 mg, deux fois par jour, par voie orale) de 4 jours \u00e0 6-7 jours ont permis d&rsquo;am\u00e9liorer les taux de r\u00e9ponse et de r\u00e9mission, en particulier chez les patients co-infect\u00e9s par Bartonella.<\/p>\n\n\n\n<p>Les auteurs pensent que le pyrazinamide peut \u00e9galement avoir \u00e9t\u00e9 utile pour induire des taux de r\u00e9mission pour la Bartonellose, mais estiment que des \u00e9tudes contr\u00f4l\u00e9es de plus grande envergure seront n\u00e9cessaires pour d\u00e9terminer son effet b\u00e9n\u00e9fique.<\/p>\n\n\n\n<p>Pour en savoir plus\u00a0: Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease\/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections<\/p>\n\n\n\n<p><a href=\"https:\/\/doi.org\/10.3390\/microorganisms11092301\">https:\/\/doi.org\/10.3390\/microorganisms11092301<\/a><\/p>\n<div class=\"like-button\" style=\"float: right; clear: both; text-align: right; width = 100%;\">\n<!-- Facebook Like Button Vivacity Infotech BEGIN -->\n<div class=\"fb-like\" data-href=\"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/\" data-layout=\"box_count\" data-action=\"like\" data-show-faces=\"false\" data-size=\"large\" data-width=\"450\" data-share=\"1\" ><\/div><\/div>\n<!-- Facebook Like Button Vivacity Infotech END -->\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":17,"featured_media":3172,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[104],"tags":[],"class_list":["post-15382","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-recherche"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>R\u00e9sultats du protocole du Dr Horowitz \u00e0 base de Dapsone \u00e0 haute dose dans le traitement de la maladie de Lyme chronique et des co-infections associ\u00e9es - Association France Lyme<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9sultats du protocole du Dr Horowitz \u00e0 base de Dapsone \u00e0 haute dose dans le traitement de la maladie de Lyme chronique et des co-infections associ\u00e9es - Association France Lyme\" \/>\n<meta property=\"og:url\" content=\"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/\" \/>\n<meta property=\"og:site_name\" content=\"Association France Lyme\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/france.lyme\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-19T12:03:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-04T16:23:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/francelyme.fr\/site\/wp-content\/uploads\/2014\/10\/m_horowitz.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"360\" \/>\n\t<meta property=\"og:image:height\" content=\"295\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"adminntlyme\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@francelyme\" \/>\n<meta name=\"twitter:site\" content=\"@francelyme\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminntlyme\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\\\/\"},\"author\":{\"name\":\"adminntlyme\",\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/#\\\/schema\\\/person\\\/f7bd0eb75be49e4795c4ea0b3767e039\"},\"headline\":\"R\u00e9sultats du protocole du Dr Horowitz \u00e0 base de Dapsone \u00e0 haute dose dans le traitement de la maladie de Lyme chronique et des co-infections associ\u00e9es\",\"datePublished\":\"2023-10-19T12:03:34+00:00\",\"dateModified\":\"2024-02-04T16:23:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\\\/\"},\"wordCount\":682,\"publisher\":{\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/wp-content\\\/uploads\\\/2014\\\/10\\\/m_horowitz.jpg\",\"articleSection\":[\"Recherche\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\\\/\",\"url\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\\\/\",\"name\":\"R\u00e9sultats du protocole du Dr Horowitz \u00e0 base de Dapsone \u00e0 haute dose dans le traitement de la maladie de Lyme chronique et des co-infections associ\u00e9es - Association France Lyme\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/wp-content\\\/uploads\\\/2014\\\/10\\\/m_horowitz.jpg\",\"datePublished\":\"2023-10-19T12:03:34+00:00\",\"dateModified\":\"2024-02-04T16:23:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/francelyme.fr\\\/site\\\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\\\/#primaryimage\",\"url\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/wp-content\\\/uploads\\\/2014\\\/10\\\/m_horowitz.jpg\",\"contentUrl\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/wp-content\\\/uploads\\\/2014\\\/10\\\/m_horowitz.jpg\",\"width\":360,\"height\":295,\"caption\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R\u00e9sultats du protocole du Dr Horowitz \u00e0 base de Dapsone \u00e0 haute dose dans le traitement de la maladie de Lyme chronique et des co-infections associ\u00e9es\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/\",\"name\":\"Association France Lyme\",\"description\":\"Association de lutte contre les maladies vectorielles \u00e0 tiques\",\"publisher\":{\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/#organization\",\"name\":\"France Lyme\",\"url\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/francelyme-site.gif\",\"contentUrl\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/francelyme-site.gif\",\"width\":180,\"height\":180,\"caption\":\"France Lyme\"},\"image\":{\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/france.lyme\",\"https:\\\/\\\/x.com\\\/francelyme\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClMCGl3dvkz0iAgXFR1NH1A\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/#\\\/schema\\\/person\\\/f7bd0eb75be49e4795c4ea0b3767e039\",\"name\":\"adminntlyme\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e9ab07a36659baa27b55dfef2a5432041c212015f8eb8a8d25b934c17a03cb54?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e9ab07a36659baa27b55dfef2a5432041c212015f8eb8a8d25b934c17a03cb54?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e9ab07a36659baa27b55dfef2a5432041c212015f8eb8a8d25b934c17a03cb54?s=96&d=mm&r=g\",\"caption\":\"adminntlyme\"},\"url\":\"https:\\\/\\\/francelyme.fr\\\/site\\\/author\\\/adminntlyme\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"R\u00e9sultats du protocole du Dr Horowitz \u00e0 base de Dapsone \u00e0 haute dose dans le traitement de la maladie de Lyme chronique et des co-infections associ\u00e9es - Association France Lyme","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9sultats du protocole du Dr Horowitz \u00e0 base de Dapsone \u00e0 haute dose dans le traitement de la maladie de Lyme chronique et des co-infections associ\u00e9es - Association France Lyme","og_url":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/","og_site_name":"Association France Lyme","article_publisher":"https:\/\/www.facebook.com\/france.lyme","article_published_time":"2023-10-19T12:03:34+00:00","article_modified_time":"2024-02-04T16:23:48+00:00","og_image":[{"width":360,"height":295,"url":"https:\/\/francelyme.fr\/site\/wp-content\/uploads\/2014\/10\/m_horowitz.jpg","type":"image\/jpeg"}],"author":"adminntlyme","twitter_card":"summary_large_image","twitter_creator":"@francelyme","twitter_site":"@francelyme","twitter_misc":{"\u00c9crit par":"adminntlyme","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/#article","isPartOf":{"@id":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/"},"author":{"name":"adminntlyme","@id":"https:\/\/francelyme.fr\/site\/#\/schema\/person\/f7bd0eb75be49e4795c4ea0b3767e039"},"headline":"R\u00e9sultats du protocole du Dr Horowitz \u00e0 base de Dapsone \u00e0 haute dose dans le traitement de la maladie de Lyme chronique et des co-infections associ\u00e9es","datePublished":"2023-10-19T12:03:34+00:00","dateModified":"2024-02-04T16:23:48+00:00","mainEntityOfPage":{"@id":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/"},"wordCount":682,"publisher":{"@id":"https:\/\/francelyme.fr\/site\/#organization"},"image":{"@id":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/#primaryimage"},"thumbnailUrl":"https:\/\/francelyme.fr\/site\/wp-content\/uploads\/2014\/10\/m_horowitz.jpg","articleSection":["Recherche"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/","url":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/","name":"R\u00e9sultats du protocole du Dr Horowitz \u00e0 base de Dapsone \u00e0 haute dose dans le traitement de la maladie de Lyme chronique et des co-infections associ\u00e9es - Association France Lyme","isPartOf":{"@id":"https:\/\/francelyme.fr\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/#primaryimage"},"image":{"@id":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/#primaryimage"},"thumbnailUrl":"https:\/\/francelyme.fr\/site\/wp-content\/uploads\/2014\/10\/m_horowitz.jpg","datePublished":"2023-10-19T12:03:34+00:00","dateModified":"2024-02-04T16:23:48+00:00","breadcrumb":{"@id":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/#primaryimage","url":"https:\/\/francelyme.fr\/site\/wp-content\/uploads\/2014\/10\/m_horowitz.jpg","contentUrl":"https:\/\/francelyme.fr\/site\/wp-content\/uploads\/2014\/10\/m_horowitz.jpg","width":360,"height":295,"caption":""},{"@type":"BreadcrumbList","@id":"https:\/\/francelyme.fr\/site\/resultats-du-protocole-du-dr-horowitz-a-base-de-dapsone-a-haute-dose-dans-le-traitement-de-la-maladie-de-lyme-chronique-et-des-co-infections-associees\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/francelyme.fr\/site\/"},{"@type":"ListItem","position":2,"name":"R\u00e9sultats du protocole du Dr Horowitz \u00e0 base de Dapsone \u00e0 haute dose dans le traitement de la maladie de Lyme chronique et des co-infections associ\u00e9es"}]},{"@type":"WebSite","@id":"https:\/\/francelyme.fr\/site\/#website","url":"https:\/\/francelyme.fr\/site\/","name":"Association France Lyme","description":"Association de lutte contre les maladies vectorielles \u00e0 tiques","publisher":{"@id":"https:\/\/francelyme.fr\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/francelyme.fr\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/francelyme.fr\/site\/#organization","name":"France Lyme","url":"https:\/\/francelyme.fr\/site\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/francelyme.fr\/site\/#\/schema\/logo\/image\/","url":"https:\/\/francelyme.fr\/site\/wp-content\/uploads\/2019\/05\/francelyme-site.gif","contentUrl":"https:\/\/francelyme.fr\/site\/wp-content\/uploads\/2019\/05\/francelyme-site.gif","width":180,"height":180,"caption":"France Lyme"},"image":{"@id":"https:\/\/francelyme.fr\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/france.lyme","https:\/\/x.com\/francelyme","https:\/\/www.youtube.com\/channel\/UClMCGl3dvkz0iAgXFR1NH1A"]},{"@type":"Person","@id":"https:\/\/francelyme.fr\/site\/#\/schema\/person\/f7bd0eb75be49e4795c4ea0b3767e039","name":"adminntlyme","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/e9ab07a36659baa27b55dfef2a5432041c212015f8eb8a8d25b934c17a03cb54?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9ab07a36659baa27b55dfef2a5432041c212015f8eb8a8d25b934c17a03cb54?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9ab07a36659baa27b55dfef2a5432041c212015f8eb8a8d25b934c17a03cb54?s=96&d=mm&r=g","caption":"adminntlyme"},"url":"https:\/\/francelyme.fr\/site\/author\/adminntlyme\/"}]}},"_links":{"self":[{"href":"https:\/\/francelyme.fr\/site\/wp-json\/wp\/v2\/posts\/15382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/francelyme.fr\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/francelyme.fr\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/francelyme.fr\/site\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/francelyme.fr\/site\/wp-json\/wp\/v2\/comments?post=15382"}],"version-history":[{"count":2,"href":"https:\/\/francelyme.fr\/site\/wp-json\/wp\/v2\/posts\/15382\/revisions"}],"predecessor-version":[{"id":15788,"href":"https:\/\/francelyme.fr\/site\/wp-json\/wp\/v2\/posts\/15382\/revisions\/15788"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/francelyme.fr\/site\/wp-json\/wp\/v2\/media\/3172"}],"wp:attachment":[{"href":"https:\/\/francelyme.fr\/site\/wp-json\/wp\/v2\/media?parent=15382"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/francelyme.fr\/site\/wp-json\/wp\/v2\/categories?post=15382"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/francelyme.fr\/site\/wp-json\/wp\/v2\/tags?post=15382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}